Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
AstraZeneca is listing in New York, as Big Pharma balances the huge U.S. market with China's tempting innovation
AstraZeneca has announced it's investing $15 billions in China, and said it is partnering with a Chinese biotech to develop weight-loss drugs. The developments come at a critical time for the pharma industry as companies are increasingly looking…
Biological weapons convention and the perpetuation of the pandemic preparedness pharma-industrial complex
Robert Malone authored an article a few days ago on potential updates to the Biological Weapons Convention (BWC) arising from lessons from Covid-19, (supposed) rapid advances in biotechnology and the threat presented by low- probability…
From COVID Triumph to Self-Reliance: Major Bio-Pharma Boost in Union Budget 2026
New Delhi: Union Budget 2026: In a significant move to bolster India's healthcare infrastructure and reduce dependency on imports, Finance Minister Nirmala Sitharaman unveiled the 'Biopharma SHAKTI' initiative in the Union Budget 2026-27…
Sun Pharma shares end nearly 1% higher post earnings announcement
Shares of Sun Pharmaceutical Industries on Sunday ended nearly 1 per cent higher after the firm posted a 16 per cent increase in its consolidated net profit for the third quarter ended December 31, 2025. The stock ended at ₹1,610.20, up 0.95…
Growth in the post-Lenalidomide era for pharma stocks
Cipla and Dr. Reddy's have posted their Q3FY26 results and as was expected, did not fare well with 57 per cent and 15 per cent year-on-year decline in profits respectively, despite 0.2 per cent and 4 per cent revenue growth. The US, which accounts…
Sun Pharma will be 'disciplined' about acquisitions, looking at 'tuck-ins' in emerging markets: Dilip Shanghvi
Sun Pharmaceutical Industries will look at strategic acquisitions, including smaller “tuck-ins,” top-management said, outlining strategy, without commenting on specifics being reported in the media. The company will look at…
BridgeBio Pharma, Inc. $BBIO Shares Acquired by Federated Hermes Inc.
Federated Hermes Inc. increased its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 53.0% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 424,695 shares of the…
Budget 2026-27: Sitharaman proposes 5 medical hubs, Rs 12.2 lakh crore capex, bio pharma boost, and financial sector reforms for Viksit Bharat
Union Finance Minister Nirmala Sitharaman on Sunday presented the Union Budget 2026-27, marking her ninth consecutive Budget presentation. The proposals, aimed at strengthening India's economic and social infrastructure, focus on healthcare…
Why The Markets Fell After 12.10 PM
Ambareesh Baliga's quick take on the markets after the increase in STT on futures trading to 0.05% (0.02% earlier) and on options to to 0.15% (0.1% earlier) Soon after Finance Minister Nirmala Sitharaman announced the proposal to increase the…
How stock markets will fare on this Budget Day
Stock market benchmark indices Sensex and Nifty fluctuated in a narrow range in early trade on Sunday ahead of the Budget 2026-27 presentation. After opening the day on a positive note, the 30-share BSE Sensex later fluctuated and quoted 13 points…
Budget 2026: STT Hike and Tobacco Tax Shock Sink Nifty; Over ₹9 Trillion Wiped Out
What began as a hopeful special Sunday trading session ended in a full-blown rout for Indian equities. While the Union Budget 2026 focused on long-term manufacturing, it dealt two immediate blows to market sentiment: an increase in the tax on…
Markets Plunge as Budget 2026 Announcements Trigger Sharp Sell-Off; PSU Banks and Metals Bleed
In a dramatic turn of events, the Indian equity markets shifted from a cautious start to a broad-based sell-off as Finance Minister Nirmala Sitharaman delivered the Union Budget 2026 speech. What began as a relatively flat Sunday special session…
Union Budget 2026: Top stocks likely to benefit, Which shares could see a boost? | Dynamite News
Ahead of Union Budget 2026-27, investors are closely watching the stock market for potential opportunities. Key sectors likely to benefit include automobile, electric vehicles, railway, and pharmaceutical companies. Updated: 1 February 2026, 10:49…
Budget 2026: Stock markets fluctuate in narrow range
Stock market benchmark indices Sensex and Nifty fluctuated in a narrow range in early trade on Sunday (February 1, 2026) ahead of the Budget 2026-27 presentation. After opening the day on a positive note, the 30-share BSE Sensex later fluctuated…
Union Budget 2026: What's in Biopharma SHAKTI scheme announced by FM Sitharaman
6 min read New Delhi Make us preferred source on Google Finance Minister Nirmala Sitharaman announced the Biopharma SHAKTI scheme as part of the Union Budget 2026, aiming to make India a global manufacturing hub for biopharma. “India's…
Receive a Daily briefing on Pharma Industry News
Get Started